Rebamipide (Regular & Nanoparticulated) vs. Clobetasol in Management of Methotrexate-Induced Oral Ulceration in Rheumatoid Arthritis Patients
Clinical trial NCT04649697 · UNKNOWN
Trial details
- NCT number
- NCT04649697
- Sponsor
- Cairo University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-12-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.